The authors reply

Geahča maid

• Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study
  Dahkki: Judge, PK, et al.
  Almmustuhtton: (2023)
• Allocated but not treated: the silent 16% – Authors' reply
  Dahkki: Horby, P, et al.
  Almmustuhtton: (2022)
• Authors' reply
  Dahkki: Herrington, W, et al.
  Almmustuhtton: (2018)
• Impact of primary kidney disease on the effects of empagliflozin in patients with CKD
  Dahkki: Judge, PK, et al.
  Almmustuhtton: (2023)
• The prevention and management of chronic kidney disease among patients with metabolic syndrome
  Dahkki: Zhu, D, et al.
  Almmustuhtton: (2025)